TL-895 is a potent, orally active, ATP-competitive, and highly selective irreversible BTK inhibitor with an IC 50 and a K i of 1.5 nM and 11.9 nM, respectively TL-895 is used be for JAKi-relapsed/refractory myelofibrosis, acute myeloid leukemia, COVID-19 and cancer researchForm:SolidIC50& Target:IC50: 1.5 nM,Ki: 11.9 nM (BTK).
Specifications and Purity: ≥99%
Molecular Formula: C25H26FN5O2
Molecular Weight: 447.50
- UPC:
- 42181512
- Condition:
- New
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- T649723-50mg
- CAS:
- 1415823-49-2
- Product Size:
- 50mg
akash.verma@cenmed.com
(732) 447-1115





